Globes English – Drug developer Eloxx Pharmaceuticals raises $24m
Eloxx Pharmaceuticals has raised $24 million in a series C nancing round led by Pontifax and with the participation of Catalyst CEL – Israeli Chinese fund, Quark Venture Inc. and…
Globes English – Drug developer Eloxx Pharmaceuticals raises $24m
Eloxx Pharmaceuticals has raised $24 million in a series C nancing round led by Pontifax and with the participation of Catalyst CEL – Israeli Chinese fund, Quark Venture Inc. and…
Israeli Biopharmaceutical Firm Eloxx Raises $24 Million – The New York Times
TEL AVIV — Eloxx Pharmaceuticals Ltd, a clinical stage company developing drugs for genetic diseases, raised $24 million in an investment round led by Catalyst CEL Fund and Israeli life…